Atika Capital Management LLC Pulmonx Corp Transaction History

Atika Capital Management LLC

  • $874 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$37.61 - $48.0 $3.82 Million - $4.88 Million
-101,700 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$44.0 - $67.54 $435,600 - $668,646
-9,900 Reduced 8.87%
101,700 $4.65 Million
Q4 2020

Feb 16, 2021
BUY
$39.31 - $69.02 $4.39 Million - $7.7 Million
111,600 New
111,600 $7.7 Million

Others Institutions Holding LUNG

# of Institutions
125
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $244M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email